Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Harvard Business School
Daiichi Sankyo
Farmers Insurance
Cerilliant
Mallinckrodt
Cantor Fitzgerald
UBS

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207988

« Back to Dashboard

NDA 207988 describes ZURAMPIC, which is a drug marketed by Ironwood Pharms Inc and is included in one NDA. It is available from two suppliers. There are seven patents protecting this drug. Additional details are available on the ZURAMPIC profile page.

The generic ingredient in ZURAMPIC is lesinurad. Two suppliers are listed for this compound. Additional details are available on the lesinurad profile page.
Summary for 207988
Tradename:ZURAMPIC
Applicant:Ironwood Pharms Inc
Ingredient:lesinurad
Patents:7
Pharmacology for NDA: 207988
Suppliers and Packaging for NDA: 207988
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZURAMPIC lesinurad TABLET;ORAL 207988 NDA AstraZeneca Pharmaceuticals LP 0310-1475 N 0310-1475-05
ZURAMPIC lesinurad TABLET;ORAL 207988 NDA AstraZeneca Pharmaceuticals LP 0310-1475 N 0310-1475-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Dec 22, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Dec 22, 2020
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:➤ Try a Free TrialPatent Expiration:Aug 25, 2025Product Flag?Substance Flag?YDelist Request?
Patent:➤ Try a Free TrialPatent Expiration:Aug 17, 2029Product Flag?Substance Flag?Delist Request?
Patented Use:REDUCTION OF SERUM URIC ACID LEVELS

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Medtronic
Covington
US Army
Cerilliant
AstraZeneca
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.